BIOTECH ASSISTANT / FIELD NOTES

Structural Analysis of Active Pharmaceutical Ingredients in Tablets Using 3D ED/MicroED

Academic source · Molecular Pharmaceutics

Source published:

Site published: 2026-11-03 · Updated: 2026-11-03

Explore this article with AI

This source is linked automatically. Choose a question to get started.

Ask AI ↗

What the paper reports

The study examined API crystals directly in Allegra, Clarith, and Ibrance tablets using selected-area 3D ED/MicroED. Fexofenadine hydrochloride Form I and clarithromycin Form II retained their polymorphs, while palbociclib Form A showed slight lattice shrinkage. The results demonstrate formulation-level structural analysis and emphasize that a lattice change and a new polymorph are different findings.

Why this paper is included

Direct tablet measurements make this a particularly useful reference for formulation development, manufacturing comparisons, and investigating API form changes in finished products.

The interpretation above is analysis, not a conclusion attributed to the original source.

Read the original source ↗

Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections

MicroED structure determination Pharmaceutical solid state Formulation Development & Manufacturing

Related updates

Continue your research

Explore company filters, side-by-side comparisons, private bookmarks, and member discussions.

Open free member tools ↗
AI assistant ↗